Goldman Sachs Group Inc Greenwich Life Sciences, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$8.31 - $20.32 $344,906 - $843,381
41,505 New
41,505 $827,000
Q2 2022

May 14, 2024
BUY
$7.14 - $20.36 $87,979 - $250,875
12,322 New
12,322 $104,000
Q2 2022

Aug 15, 2022
BUY
$7.14 - $20.36 $87,979 - $250,875
12,322 New
12,322 $104,000

Others Institutions Holding GLSI

# of Institutions
38
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About Greenwich LifeSciences, Inc.

GLSI Quotes by TradingView
  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $158M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email